SCHEMBL20836154

SCHEMBL20836154

Cc1sc(N(C)N=Cc2ccccc2C(=O)O)nc1-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 17/20 1.00
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RARA P10276 1/20 0.43
▸ RARB P10826 1/20 0.43
▸ RARG P13631 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29859288 1.00 DHODH (1.00) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL19631362 1.00 DHODH (1.00) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL19631370 0.89 DHODH (1.00) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL20956542 0.89 DHODH (1.00) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL25613714 0.89 DHODH (0.80) DHODHMEN1KMT2AMAPK1
SCHEMBL29859659 0.89 DHODH (1.00) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL19631470 0.86 DHODH (1.00) DHODH
SCHEMBL25613978 0.84 DHODH (0.73) DHODHMEN1KMT2AMAPK1LMNA
SCHEMBL25614126 0.83 DHODH (0.71) DHODHMEN1KMT2AMAPK1RARA
SCHEMBL24142109 0.78 DHODH (0.64) DHODHMEN1KMT2AMAPK1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-28 — — US disclosed
CN-107375279-B Use of novel thiazole derivatives for the treatment of inflammatory bowel disease 华东理工大学 2022-11-01 — — CN disclosed
CN-107382902-B Thiazole derivative and application thereof 华东理工大学 2022-08-12 — — CN disclosed
CN-107459496-B Use of thiazole derivatives for treating viral infections 华东理工大学 2022-07-19 — — CN disclosed
EP-3459937-B1 THIAZOLE DERIVATIVE AND APPLICATIONS UNIV EAST CHINA SCIENCE & TECH (CN) 2021-12-29 — — EP disclosed
US-10919869-B2 Thiazole derivative and applications EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-02-16 — — US disclosed
CN-106892878-B Thiazole derivative and application thereof in inhibiting dihydroorotate dehydrogenase 华东理工大学 2020-01-10 — — CN disclosed
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-05-09 — — US disclosed
EP-3459937-A1 THIAZOLE DERIVATIVE AND APPLICATIONS East China University of Science and Technology (CN) 2019-03-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11590109-B2 Applications of novel thiazole derivative in treating virus infection HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885MEN1 4251/4885KMT2A 4585/4885
US-20190134008-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING VIRUS INFECTION HAVCR2, MAVS, EIF2AK2 DHODH 1507/4885MEN1 4251/4885KMT2A 4585/4885
US-10919869-B2 Thiazole derivative and applications DHODH, DLD, THOC2 DHODH 1/4885MEN1 3352/4885KMT2A 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback